Stock listing

NASDAQ:BOLD Audentes Therapeutics Inc Stock

Follow Audentes Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BOLD

$59.97 USD

Close on Jan 16, 2020 · No longer trades

Jul 20, 2016 to last close +296.4% · weekly closes, Jul 20, 2016 – Jan 16, 2020
Lowest – highest close
$14.11 – $60.00 USDSince Jul 20, 2016 · lowest Sep 14, 2016 · highest Jan 6, 2020

Delisted NASDAQ:BOLD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BOLD
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Audentes Therapeutics Inc on 6ix

Decks
10 decks · latest Oct 9, 2019

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 10, 2026 · Before open−0.4%
Quarter to Jun 30, 2026Aug 7, 2026−0.7%
Quarter to Mar 31, 2026May 8, 2026 · Before open−5.9%
Quarter to Dec 31, 2025Mar 26, 2026−1.8%
Quarter to Sep 30, 2025Nov 5, 2025 · Before open−3.1%
Quarter to Jun 30, 2025Aug 5, 2025 · Before open−1.7%
Quarter to Mar 31, 2025May 9, 2025 · Before open−4.0%
Quarter to Dec 31, 2024Mar 27, 2025−1.3%
Quarter to Sep 30, 2024Nov 7, 2024 · After close+5.4%
Quarter to Jun 30, 2024Aug 12, 2024 · After close+2.8%
All 12 quarters
QuarterResultsShare move
Quarter to Mar 31, 2024May 13, 2024 · Before open+10.8%
Quarter to Dec 31, 2023Feb 28, 2024

Open Events

Decks

DeckKindSlidesDate
24th International Annual Congress of the World Muscle Society (WMS) Annual Meeting 2019Conference24 slidesOct 9, 2019
Technical Presentation (May 2019)Technical29 slidesMay 1, 2019
Technical Presentation (October 2018)Technical20 slidesOct 5, 2018
Technical Presentation (May 2018)Technical16 slidesMay 16, 2018
Technical Presentation (January 2018)Technical21 slidesJan 4, 2018
Investor Presentation (September 2017)Investor deck33 slidesSep 27, 2017
Technical Presentation (September 2017)Technical23 slidesSep 27, 2017
Cowen 37th Annual Health Care Conference 2017Conference36 slidesMar 7, 2017
Investor Presentation (November 2016)Investor deck34 slidesNov 29, 2016
Investor Presentation (September 2016)Investor deck34 slidesSep 28, 2016

Open Decks

Cap table

Built by 6ix from Audentes Therapeutics Inc’s releases

Common shares
23,108,935
Fully diluted
23,108,935

Fully diluted

LineShares
Common shares23,108,935

Share count over time

CountShares
Nov 22, 202623,108,935

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Dec 11, 2017 – Jan 15, 2020 · Past
Edward R. Conner
Other companies: Jade Biosciences, Inc. (Chief Medical Officer · Since at least Apr 23, 2026); Ardelyx, Inc. (Chief Medical Officer · Since at least Aug 1, 2025); Third Harmonic Bio Inc. (Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past)
SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past
Louis G Lange
Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jul 1, 2013 · Past); Maxygen Inc (Director · May 27, 2010 – Jun 6, 2012 · Past)
Director · Jul 19, 2016 – Jan 15, 2020 · Past
Matthew R Patterson
Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past)
Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past
Thomas J. Schuetz
Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past)
Director · Jul 19, 2016 – Jan 15, 2020 · Past
Mary NewmanSVP, Regulatory Affairs · Jul 19, 2016 – Nov 15, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Audentes Therapeutics Inc.